Stocks
Arcutis Biotherapeutics (ARQT) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -7 991% | -381.6% | -81.3% | |||||
| Changes by years, y/y, % | +7 610pp | -95.2% | |||||||
Arcutis Biotherapeutics. EBITDA margin, %
Arcutis Biotherapeutics. EBITDA margin, changes, pp
Arcutis Biotherapeutics (ARQT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -429.6% | -63.1% | -54.9% | -144.2% | -87.3% | -81.3% | |
| Changes by years, y/y, % | +1 769pp | +2 564pp | +2 572pp | +1 082pp | +1pp | |||
| Changes by quarters, q/q, % | -341pp | +367pp | +8pp | -89pp | +57pp | |||
